CM Hospitalar S/A Income Statement

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	11,567	11,583	11,084	8,747	6,219
Revenue Growth (YoY)	-0.14%	4.51%	26.72%	40.65%	40.91%
Cost of Revenue	9,898	10,277	9,349	7,350	5,121
Gross Profit	1,669	1,306	1,735	1,397	1,097
Selling, General & Admin	1,327	1,473	1,146	863.53	671.86
Other Operating Expenses	-213.54	537.62	-41.01	10.28	-71.19
Operating Expenses	1,140	2,121	1,097	879.77	602.01
Operating Income	528.89	-814.99	638.13	516.89	495.3
Interest Expense	-590.9	-489.45	-660.37	-	-386.75
Interest & Investment Income	70.89	91.12	162.42	-	303.31
Earnings From Equity Investments	-1	-11.86	-1.68	-3.53	-3
Currency Exchange Gain (Loss)	21.11	-54.93	-	-	-
Other Non Operating Income (Expenses)	12.92	-275.31	-	-305.28	-
EBT Excluding Unusual Items	41.9	-1,555	138.5	208.08	408.85
Asset Writedown	-5.58	-45.58	-	-	-
Legal Settlements	9.36	9.44	-	-	-
Pretax Income	45.67	-1,592	138.5	208.08	408.85
Income Tax Expense	27.44	-176.06	-221.42	-51.65	13.7
Earnings From Continuing Operations	18.24	-1,415	359.92	259.73	395.16
Net Income	18.24	-1,415	359.92	259.73	395.16
Net Income to Common	18.24	-1,415	359.92	259.73	395.16
Net Income Growth	-	-	38.57%	-34.27%	224.52%
Shares Outstanding (Basic)	316	318	300	284	262
Shares Outstanding (Diluted)	316	318	300	284	262
Shares Change (YoY)	-0.59%	5.88%	5.74%	8.48%	16.35%
EPS (Basic)	0.06	-4.46	1.20	0.92	1.51
EPS (Diluted)	0.06	-4.46	1.20	0.92	1.51
EPS Growth	-	-	31.05%	-39.41%	178.91%
Free Cash Flow	231.09	-47.47	-1,064	380.51	242.16
Free Cash Flow Per Share	0.73	-0.15	-3.54	1.34	0.93
Dividend Per Share	-	-	0.137	0.277	0.405
Dividend Growth	-	-	-50.69%	-31.57%	-
Gross Margin	14.43%	11.27%	15.65%	15.97%	17.64%
Operating Margin	4.57%	-7.04%	5.76%	5.91%	7.96%
Profit Margin	0.16%	-12.22%	3.25%	2.97%	6.35%
Free Cash Flow Margin	2.00%	-0.41%	-9.60%	4.35%	3.89%
EBITDA	632.22	-621.21	898.74	693.25	593.49
EBITDA Margin	5.47%	-5.36%	8.11%	7.93%	9.54%
D&A For EBITDA	103.33	193.77	260.61	176.36	98.19
EBIT	528.89	-814.99	638.13	516.89	495.3
EBIT Margin	4.57%	-7.04%	5.76%	5.91%	7.96%
Effective Tax Rate	60.07%	-	-	-	3.35%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.